Last reviewed · How we verify
Gonal-F, Fostimon
Gonal-F, Fostimon is a FSH analog Small molecule drug developed by Genesis Center for Fertility & Human Pre-Implantation Genetics. It is currently in Phase 2 development for Induction of ovulation and pregnancy in infertile women with anovulatory polycystic ovary syndrome (PCOS). Also known as: Recombinant Gonadotropin, Highly purified Gonadotropin, Gonal-F, Fostimon.
Stimulates the production of follicle-stimulating hormone (FSH)
Stimulates the production of follicle-stimulating hormone (FSH) Used for Induction of ovulation and pregnancy in infertile women with anovulatory polycystic ovary syndrome (PCOS).
At a glance
| Generic name | Gonal-F, Fostimon |
|---|---|
| Also known as | Recombinant Gonadotropin, Highly purified Gonadotropin, Gonal-F, Fostimon |
| Sponsor | Genesis Center for Fertility & Human Pre-Implantation Genetics |
| Drug class | FSH analog |
| Target | FSH receptor |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 2 |
Mechanism of action
Gonal-F and Fostimon are recombinant human FSH products used to stimulate follicular growth in women with diminished ovarian function.
Approved indications
- Induction of ovulation and pregnancy in infertile women with anovulatory polycystic ovary syndrome (PCOS)
Common side effects
- Ovarian hyperstimulation syndrome (OHSS)
- Headache
- Nausea
Key clinical trials
- C677T Methylenetetrahydrofolate Reductase Mutation
- Tailored Ovarian Stimulation Based on BMI, AMH, AFC (PHASE4)
- Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle
- FSH Followed by HMG vs FSH Plus HMG in IVF (PHASE4)
- FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST) (PHASE4)
- Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment (NA)
- Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI. (PHASE3)
- Clinical Efficacy and Tolerability of Two FSH Preparations (Human FSH Versus rFSH - Follitropin Alpha) in Women Undergoing IVF (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Gonal-F, Fostimon CI brief — competitive landscape report
- Gonal-F, Fostimon updates RSS · CI watch RSS
- Genesis Center for Fertility & Human Pre-Implantation Genetics portfolio CI
Frequently asked questions about Gonal-F, Fostimon
What is Gonal-F, Fostimon?
How does Gonal-F, Fostimon work?
What is Gonal-F, Fostimon used for?
Who makes Gonal-F, Fostimon?
Is Gonal-F, Fostimon also known as anything else?
What drug class is Gonal-F, Fostimon in?
What development phase is Gonal-F, Fostimon in?
What are the side effects of Gonal-F, Fostimon?
What does Gonal-F, Fostimon target?
Related
- Drug class: All FSH analog drugs
- Target: All drugs targeting FSH receptor
- Manufacturer: Genesis Center for Fertility & Human Pre-Implantation Genetics — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Induction of ovulation and pregnancy in infertile women with anovulatory polycystic ovary syndrome (PCOS)
- Also known as: Recombinant Gonadotropin, Highly purified Gonadotropin, Gonal-F, Fostimon
- Compare: Gonal-F, Fostimon vs similar drugs
- Pricing: Gonal-F, Fostimon cost, discount & access